| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001048187A3 A molecular switch for regulating mammalian gene expression |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | WO2000051567A8 Processes for making pharmaceutical oral ecb formulations and compositions |
| 05/30/2002 | WO2000051564A8 Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
| 05/30/2002 | WO2000024411A3 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds |
| 05/30/2002 | US20020065418 Viral polymerase inhibitors |
| 05/30/2002 | US20020065407 Nucleotide sequences coding preferential polypeptide for use in the immunization of animal against viral diseases |
| 05/30/2002 | US20020065397 Protecting therapeutic compositions from host-mediated inactivation |
| 05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
| 05/30/2002 | US20020065322 Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 05/30/2002 | US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc. |
| 05/30/2002 | US20020065310 Method for treatment of tumors using nordihydroguaiaretic acid derivatives |
| 05/30/2002 | US20020065302 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065280 Oxazolidinones to treat eye infections |
| 05/30/2002 | US20020065279 Arylsulfonic acid salts of pyrimidine-based antiviral |
| 05/30/2002 | US20020065272 Olanzapine-N-oxide compositions and methods |
| 05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
| 05/30/2002 | US20020065263 Formulation |
| 05/30/2002 | US20020065248 Pyrrolopyrazinones useful as serine protease inhibitors |
| 05/30/2002 | US20020065235 Ketolide antibiotics |
| 05/30/2002 | US20020065227 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064859 Nuclelotide sequences coding heterologous protein for use in the treatment of cancer, infections, genetic and immunological disorder |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064566 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 05/30/2002 | US20020064565 Treating an eye infections; cleansing a contact lens in place on an eye |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
| 05/30/2002 | US20020064534 Herpesvirus preparations and their uses |
| 05/30/2002 | US20020064532 Virus mutant of given nucleotide sequence; vaccine can be administered to poultry by mass application routes |
| 05/30/2002 | US20020064524 Formulation for topical non-invasive application in vivo |
| 05/30/2002 | US20020064505 Oral anti-odor compositions |
| 05/30/2002 | EP1143986A3 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds |
| 05/30/2002 | CA2430202A1 Method for treating hiv |
| 05/30/2002 | CA2430113A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |
| 05/30/2002 | CA2429976A1 Polysaccharide compound having immune stimulating activity |
| 05/30/2002 | CA2429675A1 Novel carbapenem derivatives |
| 05/30/2002 | CA2429649A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2429576A1 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | CA2429467A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/30/2002 | CA2428461A1 Imidazolone derivatives for the treatment of viral diseases |
| 05/30/2002 | CA2428459A1 Novel compounds for use as hiv protease inhibitors |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | CA2427661A1 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | CA2427334A1 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | CA2427284A1 Antiinflammation agents |
| 05/30/2002 | CA2426939A1 Cystoskeleton-associated proteins |
| 05/29/2002 | EP1209240A1 Novel compound f-15078 |
| 05/29/2002 | EP1209166A1 Novel a-500359 derivatives |
| 05/29/2002 | EP1208844A1 Therapeutic agent for mastitis of livestock and method for treating mastitis using the same agent |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/29/2002 | EP1208839A1 Chelate compound for treating Helicobacter pylori infections |
| 05/29/2002 | EP1208384A2 Methods and compositions for modulating oxidized ldl transport |
| 05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 05/29/2002 | EP1208234A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 05/29/2002 | EP1208228A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 05/29/2002 | EP1208214A2 Genetically engineered bleb vaccine |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208100A1 Selective antagonists of a2b adenosine receptors |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP1207912A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 05/29/2002 | EP1207907A2 Compositions for treating viral infections, and methods therefor |
| 05/29/2002 | EP1207901A2 Use of natriuretic peptides as antibiotically effective substances for treating bacterial infections |
| 05/29/2002 | EP1207890A2 Antiviral prodrugs |
| 05/29/2002 | EP1207881A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 05/29/2002 | EP1207876A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 05/29/2002 | EP1207871A2 Use of thiamphenicol in the treatment of vancomycin-intermediates and multiresistant staphylococci infections |
| 05/29/2002 | EP1207869A2 Antimycotic drug |
| 05/29/2002 | EP1207865A1 Composition for treatment of infections of humans and animals |
| 05/29/2002 | EP1207861A1 Treatment of fungal infections utilizing a fungal growth medium |
| 05/29/2002 | EP1207860A1 Controlled release pellet formulation |
| 05/29/2002 | EP1207859A1 Oral form of administration containing probiotic micro-organisms |
| 05/29/2002 | EP1207857A1 Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof |
| 05/29/2002 | EP1061812A4 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 05/29/2002 | EP0981646A4 Enzymatic dna molecules |
| 05/29/2002 | EP0613374B1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 05/29/2002 | DE10057976A1 Verfahren zur Herstellung von Pektinhydrolyseprodukten A process for producing pectin hydrolysis products |
| 05/29/2002 | DE10055886A1 Impfstoffe, die rekombinante Hantavirusproteine enthalten, Verfahren zu iher Herstellung und ihre Verwendung Vaccines containing recombinant Hantavirusproteine, process for preparation and their use IHER |
| 05/29/2002 | CN1351714A Tandem immuno-assay for cancer |
| 05/29/2002 | CN1351662A Inhibition of viral infection using monovalent antigen-binding proteins |
| 05/29/2002 | CN1351653A Anti-bacterial vaccine compositions |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351611A Long lasting fusion peptide inhibitors of viral infection |
| 05/29/2002 | CN1351608A B-methyl-erythromycin derivatives |
| 05/29/2002 | CN1351607A Novel crystalline forms of macrolide antibiotic |
| 05/29/2002 | CN1351606A Halo derivatives of 9-Deoxo-9a-Aza-9a-Homery theromycin A |
| 05/29/2002 | CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |